INIS
patients
100%
mortality
100%
pneumonia
100%
monocytes
100%
adults
42%
cytokines
42%
levels
28%
hospitals
28%
control
28%
colombia
14%
risks
14%
risk assessment
14%
death
14%
reduction
14%
phenotype
14%
universities
14%
probability
14%
laboratories
14%
immunosuppression
14%
pathogenesis
14%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
HLA-DR
100%
Mortality Rate
100%
Cytokine
50%
CD14
33%
CD16
33%
Immunosuppression
16%
Coinfection
16%
Real-Time Polymerase Chain Reaction
16%
Programmed Death-Ligand 1
16%
Interleukin 6
16%
Interleukin 10
16%
Comorbidity
16%
Interleukin 8
16%
Medicine and Dentistry
Mortality Rate
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Cytokine
50%
Infection
33%
Immunosuppressive Treatment
16%
Mixed Infection
16%
Prospective Cohort Study
16%
Predictive Marker
16%
Real-Time Polymerase Chain Reaction
16%
Programmed Death-Ligand 1
16%
Interleukin 10
16%
Interleukin 6
16%
Comorbidity
16%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Mortality Rate
100%
Cytokine
50%
Infection
33%
Prospective Cohort Study
16%
Mixed Infection
16%
Interleukin 10
16%
Interleukin 6
16%
Comorbidity
16%
Keyphrases
HLA-DR Expression
50%
Public Teaching Hospitals
25%
Phenotype Profiles
25%
Independent Predictors of Mortality
25%
IL-6 Cytokine
25%
Early Reduction
25%
Monocyte Phenotype
25%
Tertiary Level
25%
Routine Laboratory Parameters
25%